SCARB1 and nasopharyngeal carcinoma: Previous reports have indicated that SR-B1 is highly expressed in numerous tumor cells, such as in hepatoma, prostate, breast, colorectal, pancreatic, ovarian, and nasopharyngeal cancers 8-11.